GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaResearch Co Ltd (XKRX:214450) » Definitions » Cyclically Adjusted Book per Share

PharmaResearch Co (XKRX:214450) Cyclically Adjusted Book per Share : ₩31,719.28 (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is PharmaResearch Co Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

PharmaResearch Co's adjusted book value per share for the three months ended in Mar. 2025 was ₩54,554.155. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₩31,719.28 for the trailing ten years ended in Mar. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2025-06-02), PharmaResearch Co's current stock price is ₩451000.00. PharmaResearch Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was ₩31,719.28. PharmaResearch Co's Cyclically Adjusted PB Ratio of today is 14.22.

During the past 11 years, the highest Cyclically Adjusted PB Ratio of PharmaResearch Co was 14.22. The lowest was 4.67. And the median was 7.95.


PharmaResearch Co Cyclically Adjusted Book per Share Historical Data

The historical data trend for PharmaResearch Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaResearch Co Cyclically Adjusted Book per Share Chart

PharmaResearch Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 30,698.17

PharmaResearch Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 28,469.84 29,261.96 30,698.17 31,719.28

Competitive Comparison of PharmaResearch Co's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, PharmaResearch Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaResearch Co's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaResearch Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where PharmaResearch Co's Cyclically Adjusted PB Ratio falls into.


;
;

PharmaResearch Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PharmaResearch Co's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=54554.155/122.5900*122.5900
=54,554.155

Current CPI (Mar. 2025) = 122.5900.

PharmaResearch Co Quarterly Data

Book Value per Share CPI Adj_Book
201506 0.000 100.051 0.000
201509 0.000 100.111 0.000
201512 17,104.619 100.220 20,922.439
201603 0.000 100.561 0.000
201606 0.000 100.791 0.000
201609 18,304.187 101.461 22,115.945
201612 18,255.830 101.561 22,035.777
201703 18,277.305 102.851 21,785.141
201706 18,700.756 102.611 22,341.844
201709 19,283.118 103.491 22,841.879
201712 19,149.095 102.991 22,793.177
201803 19,634.499 104.101 23,121.755
201806 19,616.630 104.130 23,094.168
201809 19,811.102 105.651 22,987.520
201812 20,892.633 104.351 24,544.425
201903 21,072.318 104.491 24,722.301
201906 21,447.939 104.881 25,069.415
201909 21,809.674 105.200 25,414.832
201912 22,197.138 105.121 25,885.783
202003 22,482.508 105.354 26,160.615
202006 23,548.092 105.112 27,463.716
202009 24,356.025 106.198 28,115.561
202012 25,424.511 105.765 29,468.908
202103 26,309.178 107.357 30,042.160
202106 27,438.611 107.579 31,267.365
202109 28,767.270 108.759 32,425.575
202112 30,617.697 109.676 34,222.709
202203 30,892.632 111.848 33,859.593
202206 31,840.462 114.072 34,217.967
202209 33,476.519 114.715 35,774.535
202212 34,432.944 115.179 36,648.411
202303 35,748.783 116.507 37,615.150
202306 38,152.448 117.182 39,913.166
202309 40,820.113 118.964 42,064.444
202312 42,461.141 118.837 43,802.073
202403 43,217.686 120.123 44,105.186
202406 46,706.627 120.007 47,711.809
202409 49,306.484 120.861 50,011.765
202412 52,146.395 121.135 52,772.659
202503 54,554.155 122.590 54,554.155

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


PharmaResearch Co  (XKRX:214450) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

PharmaResearch Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=451000.00/31719.28
=14.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 11 years, the highest Cyclically Adjusted PB Ratio of PharmaResearch Co was 14.22. The lowest was 4.67. And the median was 7.95.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


PharmaResearch Co Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of PharmaResearch Co's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaResearch Co Business Description

Industry
Traded in Other Exchanges
N/A
Address
74 Pangyo-ro 255beon-gil, Bundang-gu, Gyeonggi-do, Seongnam, KOR, 463-400
PharmaResearch Co Ltd formerly Pharma Research Products Co Ltd is a bio pharmaceutical firm which realizes a new treatment paradigm for regenerative medicine. Its products include Rejuran, Rejuvenex, and Re-An eye drops. It also provides medical devices, cosme ceuticals, and dietary supplements.

PharmaResearch Co Headlines

No Headlines